CMS Biofeedback Therapy Coverage for Urinary Incontinence: What Billing Teams Need to Know About NCD 42
CMS has modified National Coverage Determination (NCD) 42, which governs Medicare coverage of biofeedback therapy for the treatment of urinary incontinence. This policy update affects urology, urogynecology, physical therapy, and any outpatient practice billing biofeedback-assisted pelvic muscle exercise (PME) services to Medicare patients. Understanding the precise medical necessity criteria and coverage limitations in this NCD is essential for avoiding denials and maintaining compliance.
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Biofeedback Therapy for the Treatment of Urinary Incontinence |
| Policy Code | NCD 42 |
| Change Type | Modified |
| Effective Date | 2026-03-12 |
| Impact Level | Medium |
| Specialties Affected | Urology, Urogynecology, Physical Therapy (Outpatient), Women's Health, Geriatrics |
| Key Action | Audit your biofeedback claims to confirm documented PME trial failure before billing Medicare for biofeedback-assisted therapy. |
What CMS NCD 42 Covers: Biofeedback for Urinary Incontinence
The Centers for Medicare & Medicaid Services covers biofeedback therapy for the treatment of stress and/or urge urinary incontinence—but only under a specific, narrow set of conditions. The policy is not a blanket authorization for biofeedback as a first-line intervention. Two patient-level requirements must both be met before Medicare coverage applies.
First, the patient must be cognitively intact. CMS does not cover biofeedback for patients who cannot reliably process and respond to the visual or auditory feedback signals the therapy relies on. Cognitive status should be assessed and documented in the medical record before initiating treatment.
Second, the patient must have completed a documented trial of pelvic muscle exercise (PME) training without clinically significant improvement. This prior-failure requirement is not optional—it is a hard medical necessity threshold under NCD 42.
The PME Failure Requirement: What "Failed Trial" Means Under CMS Policy
CMS defines a failed trial of PME training precisely: no clinically significant improvement in urinary incontinence after completing four weeks of an ordered plan of pelvic muscle exercises designed to increase periurethral muscle strength.
This definition has direct implications for your documentation workflow. Ordering the PME plan, tracking the patient's progress, and recording the absence of clinically significant improvement must all appear in the medical record before biofeedback is initiated. A vague note that the patient "tried Kegels" will not satisfy this requirement.
The four-week ordered plan must be structured—not self-directed exercise the patient reports anecdotally. Ordering physicians and treating practitioners should document the specific exercise regimen, the duration, and the outcome assessment used to determine clinical significance.
How CMS Defines Biofeedback Under This Policy
It's worth being precise about what CMS considers biofeedback under NCD 42, because this affects how the service is positioned in the medical record. CMS explicitly states that biofeedback is not a treatment in itself—it is a tool to help patients learn how to perform PME correctly.
Specifically, biofeedback-assisted PME uses an electronic or mechanical device to relay visual and/or auditory evidence of pelvic floor muscle tone. The goal is to improve the patient's awareness of pelvic floor musculature and assist them in performing PME with greater precision. This framing matters for documentation: the medical record should reflect biofeedback as an adjunct to PME training, not as a standalone therapeutic modality.
Where Biofeedback Is Covered—and Where It Isn't
NCD 42 limits covered biofeedback to services rendered by a practitioner in an office or other facility setting. The benefit categories that may apply include:
- Incident-to a physician's professional service
- Outpatient physical therapy services
- Physicians' services
Note that CMS explicitly states this may not be an exhaustive list of applicable benefit categories.
One coverage exclusion is unambiguous: home use of biofeedback therapy is not covered. If a patient is using a home biofeedback device, that service does not qualify for Medicare reimbursement under NCD 42, regardless of medical necessity or cognitive status.
There is also an important contractor discretion provision in this policy. CMS allows Medicare Administrative Contractors (MACs) to decide independently whether to cover biofeedback as an initial treatment modality—meaning some MAC jurisdictions may have more permissive local policies that allow biofeedback before a PME trial failure. Check your MAC's local coverage determinations (LCDs) alongside this NCD to understand what applies in your region.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
Affected Codes
The policy document for NCD 42 does not list specific CPT or HCPCS codes. Billing teams should reference their MAC's applicable LCDs and associated billing articles for the procedure codes relevant to biofeedback-assisted PME services in their jurisdiction. Contact your MAC directly or consult the CMS LCD database to identify the current applicable codes for this service in your region.
What Your Billing Team Should Do
| # | Action Item |
|---|---|
| 1 | Audit existing biofeedback claims before the March 12, 2026 effective date. Pull biofeedback claims from the past 12 months and confirm that each has documented (a) cognitive intactness and (b) a failed four-week ordered PME trial. Identify any claims that may have been submitted without this documentation and assess your exposure. |
| 2 | Update your intake and clinical documentation templates now. Work with your clinical staff to build a mandatory documentation checkpoint into the biofeedback workflow. Templates should capture the PME plan start date, the specific exercises ordered, the four-week assessment, and the outcome that established clinical failure. Verbal confirmation from a patient is not sufficient. |
| 3 | Check your MAC's local coverage policies alongside NCD 42. Because CMS permits MACs to cover biofeedback as an initial treatment modality at their discretion, your region's LCD may have different—or more permissive—criteria. Identify your MAC, pull the relevant LCD, and reconcile it with the NCD 42 requirements so your team isn't applying overly restrictive criteria unnecessarily or missing a coverage opportunity. |
| 4 | Flag home biofeedback device orders in your EHR. If any providers in your practice are ordering home biofeedback units for Medicare patients, those orders should be flagged immediately. No reimbursement pathway exists for home use under NCD 42, and billing for it creates a compliance risk. |
| 5 | Brief your urology, urogynecology, and physical therapy providers on the PME failure documentation standard. The clinical staff initiating PME plans need to understand that their documentation is the foundation of the downstream biofeedback claim. A four-week PME plan with no outcome note is a denial waiting to happen. |
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.